Bayer CropScience India vs Rallis India: Share Price, PE and ROE Compared

Bayer CropScience India MCap Rs 18,473 Cr, PE 30.64x, ROE 23.24%, Div 3.65%. Rallis India MCap Rs 4,071 Cr, PE 28.15x, ROE 8.75%.

Updated: 13 Aug 2026 • 11:35 am

Posted by:

Bayer CropScience India vs Rallis India: Share Price, PE and ROE Compared

Quick Answer

Bayer CropScience India and Rallis India are both listed crop protection companies. Bayer at Rs 18,473 Cr is about 4.5 times larger than Rallis at Rs 4,071 Cr. Bayer has a strong ROE of 23.24% with a high dividend yield of 3.65%. Rallis, the Tata Group agrochemical company, has ROE of 8.75%. Bayer's profitability and income characteristics are standout in this comparison.

The Bayer CropScience India vs Rallis India question comes up often among investors who follow the Crop protection space in India. Bayer CropScience India MCap Rs 18,473 Cr, PE 30. 64x, ROE 23. This article goes through what each company does, their latest financial performance, and the key numbers that matter for anyone evaluating Bayer CropScience India vs Rallis India as a research exercise.

All data cited here is sourced from publicly available company filings. Verify the latest prices and fundamentals on NSE or BSE before acting on any information.

Table of Contents

Bayer CropScience India vs Rallis India: Company Overview and Market Presence

Bayer CropScience India operates in the Crop protection segment and is listed on Indian exchanges. Bayer CropScience India MCap Rs 18,473 Cr, PE 30 The company has built its market position over the years through its core offerings to customers across India.

Click Here – Get Free Investment Predictions

Rallis India is the other side of this Bayer CropScience India vs Rallis India comparison. 64x, ROE 23 It competes in the same Crop protection space, though its scale and strategy may differ significantly from Bayer CropScience India's approach.

When investors look at the Bayer CropScience India vs Rallis India pair, market capitalisation is usually the first filter. Bayer CropScience India MCap Rs 18,473 Cr, PE 30. 64x, ROE 23. The size difference, if any, tells you something about liquidity and institutional ownership patterns.

Bayer CropScience India vs Rallis India: Business Mix and Revenue Sources

To understand the Bayer CropScience India vs Rallis India comparison fully, you need to look at how each company makes money. Bayer CropScience India's revenue comes from its core Crop protection operations. Bayer CropScience India earns from the Crop protection segment.

Rallis India similarly derives its earnings from the Crop protection space. Rallis India operates in the Crop protection space. The product or service mix of the two companies can be similar or quite different depending on which subsegments each one serves.

Bayer CropScience India vs Rallis India: Financial Results and Key Ratios

This is where the Bayer CropScience India vs Rallis India comparison gets concrete. Return on equity, price-to-earnings ratio and market capitalisation are three metrics that help frame the relative position of each stock.

Bayer CropScience India MCap Rs 18,473 Cr, PE 30 The profitability and efficiency ratios here reflect the latest available data from public filings.

64x, ROE 23 Both sets of numbers should be cross-checked against the latest quarterly reports from BSE or NSE before drawing any conclusions.

Compare Bayer CropScience India and Rallis India on the Univest Screener

Bayer CropScience India vs Rallis India: Valuation and What the Market Is Pricing In

Valuation is a core part of any Bayer CropScience India vs Rallis India analysis. A high PE ratio can signal growth expectations or thin earnings. A low PE may indicate value or a business under stress. Neither is automatically good or bad without context.

Bayer CropScience India MCap Rs 18,473 Cr, PE 30.64x, ROE 23.24%, Div 3.65%. Rallis India MCap Rs 4,071 Cr, PE 28.15x, ROE 8.75%. The Bayer CropScience India vs Rallis India stock data above reflects figures sourced from publicly available data. Prices change daily, so treat this as a starting point for your own research rather than a definitive trading signal.

Dividend yield is another data point worth checking in the Bayer CropScience India vs Rallis India pair. Some investors prioritise income alongside capital appreciation, and a consistent dividend track record can be a sign of earnings quality and management confidence in the cash flow.

Bayer CropScience India vs Rallis India: Side-by-Side Comparison

The table below captures the most relevant metrics side by side for the Bayer CropScience India vs Rallis India comparison.

Parameter	Bayer CropScience India	Rallis India
MCap	Rs 18,473 Cr	Rs 4,071 Cr
PE	30.64x	28.15x
ROE	23.24%	8.75%
Div	3.65%	0.53%

What Should Investors Know About the Bayer CropScience India vs Rallis India Choice

Every Bayer CropScience India vs Rallis India research exercise should go beyond just looking at the current share price. The sector outlook for Crop protection companies, the trajectory of earnings growth, debt levels and management quality all feed into a complete picture.

For the Bayer CropScience India vs Rallis India pair specifically: Bayer CropScience India MCap Rs 18,473 Cr, PE 30. 64x, ROE 23. These numbers are a starting point. Investors should also look at the trend over four to eight quarters rather than just the latest standalone figure, since one strong quarter does not always reflect the underlying business quality.

If you are building a portfolio allocation decision around the Bayer CropScience India vs Rallis India comparison, consider the risk profile of your overall portfolio first. Both companies operate in Crop protection, which carries its own sector-specific risks including regulatory changes, commodity cost pressure, competitive intensity and macroeconomic sensitivity.

Conclusion

The Bayer CropScience India vs Rallis India comparison comes down to this: Bayer CropScience India and Rallis India are both listed Indian companies in the Crop protection space, but they differ in scale, valuation, and financial profile. Bayer CropScience India MCap Rs 18,473 Cr, PE 30. 64x, ROE 23.

Bayer CropScience India MCap Rs 18,473 Cr, PE 30.64x, ROE 23.24%, Div 3.65%. Rallis India MCap Rs 4,071 Cr, PE 28.15x, ROE 8.75%. Before taking any position in either stock, verify the latest fundamentals on NSE or BSE and consult a SEBI-registered investment advisor (registration number INH000013776).

Download the Univest iOS App or Univest Android App to track Bayer CropScience India and Rallis India live and get analyst-backed stock recommendations every day.

Disclaimer: Data and figures in this article are sourced from publicly available information and may not be fully accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice from Univest (SEBI RA INH000013776).

Frequently Asked Questions

What does Bayer CropScience India do?

Ans. Bayer CropScience India is a listed Indian company in the Crop protection segment. Visit univest.in for live data.

What does Rallis India do?

Ans. Rallis India is a listed Indian company in the Crop protection segment. Visit univest.in for live data.

Which is larger in the Bayer CropScience India vs Rallis India comparison?

Ans. Based on current data: Bayer CropScience India MCap Rs 18,473 Cr, PE 30. Verify from NSE or BSE.

How do PE ratios compare in Bayer CropScience India vs Rallis India?

Ans. The PE ratio comparison is in the data table above. Verify from NSE or BSE before investing.

What is the ROE of Bayer CropScience India?

Ans. The ROE of Bayer CropScience India is listed in the comparison table above. Verify from the latest quarterly filings.

Does Rallis India pay dividends?

Ans. Dividend yield information for Rallis India is in the comparison above. Verify from NSE or BSE.

How should I evaluate Crop protection stocks?

Ans. For Crop protection stocks, review earnings quality, ROE trends, debt levels and sector outlook. Consult a SEBI-registered advisor (INH000013776) before investing.